Please assess the completion status of the following clinical trial:

Trial Title: Nutritive Effects of Cow's Milk-Based Formulas Through 18 Months of Age

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Singleton birth~* Gestational age of 37-42 weeks (36 weeks and six days is considered 36 weeks gestational age)~* Birth weight of 2500 g (5 lbs 8 oz) or more~* Parent(s) or legal guardian agrees not to enroll infant in another interventional clinical study while participating in this study~* Signed informed consent obtained for infant's participation in the study~* Signed authorization obtained to use and/or disclose Protected Health Information for infant from birth through 18 months of age~Infants receiving formula:~* 3 to 60 days of age at randomization, inclusive (day of birth is considered day 0)~* Exclusively receiving infant formula for at least 72 hours prior to randomization~* Parent(s) or legal guardian has full intention to exclusively feed study formula during the study period~Infants receiving human milk:~* 150-180 days of age at registration, inclusive (day of birth is considered day 0)~* Mother has intention to predominately provide mother's own breast milk through at least 10 months of age~Exclusion Criteria:~* Contraindication to magnetic resonance imaging (MRI)~* First degree relative with known autism, intellectual disability, schizophrenia, or bipolar disorder or an inherited disorder of myelination~* Major pre- and/or perinatal issues (such as maternal pre-eclampsia, placental abruption, maternal alcohol or illicit drug use during pregnancy)~* Major delivery complications (such as neonatal hypoxia or neonatal illness requiring a greater than 2-day NICU stay)~* Infant is immunocompromised (according to a doctor's diagnosis of immunodeficiency such as combined immunodeficiencies, DiGeorge syndrome, Wiskott-Aldrich syndrome, severe congenital neutropenia and secondary immunodeficiencies linked to HIV infection, Down syndrome or others)~* 5 minute APGAR \< 7~* Infant was born large for gestational age (LGA) (as confirmed by the hospital birth records) from mother who was diabetic at childbirth~* Infant has been identified with inadequate weight gain or failure to thrive by a health care professional (HCP)~* History of underlying metabolic or chronic disease; congenital malformation; or any other condition which, in the opinion of the Investigator, is likely to interfere with: the ability of the infant to ingest food, the normal growth and development of the infant, or the evaluation of the infant~* Parent(s) or legal guardian unable to speak English at a level to provide informed consent~Infants receiving formula:~• Evidence of feeding difficulties or history of formula intolerance, such as vomiting or poor intake at time of randomization~Infants receiving human milk:~• Use of infant formula and/or donor milk more than three times per week prior to registration

- Gender: ALL
- Minimum Age: 3 Days
- Maximum Age: 180 Days
- Healthy Volunteers: t

Study Arms:
- Control (Type: ACTIVE_COMPARATOR): None
- Investigational (Type: EXPERIMENTAL): None
- Mother's-own Breast Milk (Type: NO_INTERVENTION): None

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: enrollment issues